Fundraising FoxAndera Partners — 2024 Investments
6 investments dated 2024 · listed companies and verified rows first · show all
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsBioStar CapitalDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners
SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways.
BiotechDeep TechHealthtechMartinsried, DE
Dr. Jens Ruhe(Co-founder, Managing Director & Chief Operating Officer)Dr. Matthias Schneider(Co-founder & Chief Scientific Officer)Dr. Jan Poth(Managing Director, Chief Executive Officer)Dr. Jürgen Reeß(Chief Medical Officer)
Co-investorsHadean VenturesKurma PartnersBayern KapitalHTGFMIG Capital AGVentura BioMed Investors
Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.
BiotechDigital HealthHealthtechMedical DevicesOxford, GB
Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in
Co-investorsCanaan PartnersOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalEarlybird Venture CapitalPfizer Ventures
Skysun installs solar photovoltaic panels and battery storage systems on commercial properties—rooftops, parking areas, and land—with no upfront investment from the client.
CleantechEnergyEnterprise Software
Léopold Coppieters(Founder)inArthur Dawans(Founder)in
Co-investorsWallonie Entreprendre
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
SerenySun
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.